BMO Capital Markets began coverage on shares of UnitedHealth Group Incorporated (NYSE:UNH) in a research note published on Monday, MarketBeat reports. The firm issued an outperform rating and a $250.00 price objective on the healthcare conglomerate’s stock.
Other research analysts have also issued research reports about the company. Sanford C. Bernstein reiterated an outperform rating and issued a $190.00 price target on shares of UnitedHealth Group in a report on Monday, July 10th. Cantor Fitzgerald reiterated a buy rating and issued a $205.00 price target on shares of UnitedHealth Group in a report on Friday, July 7th. Credit Suisse Group reiterated an outperform rating and issued a $200.00 price target (up previously from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. Citigroup Inc. increased their price target on UnitedHealth Group from $195.00 to $213.00 and gave the stock a buy rating in a report on Wednesday, July 19th. Finally, Royal Bank Of Canada reiterated a buy rating and issued a $212.00 price target on shares of UnitedHealth Group in a report on Thursday, July 20th. Three analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The company has a consensus rating of Buy and a consensus target price of $215.27.
UnitedHealth Group (NYSE UNH) traded up 1.28% during trading on Monday, hitting $205.85. The stock had a trading volume of 1,067,908 shares. UnitedHealth Group has a one year low of $133.03 and a one year high of $207.80. The firm has a market capitalization of $203.59 billion, a P/E ratio of 23.37 and a beta of 0.63. The stock has a 50 day moving average of $197.17 and a 200 day moving average of $185.63.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.17 earnings per share. Equities research analysts expect that UnitedHealth Group will post $9.91 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) Now Covered by BMO Capital Markets” was posted by BBNS and is the property of of BBNS. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://baseballnewssource.com/markets/unitedhealth-group-incorporated-unh-now-covered-by-bmo-capital-markets/1720301.html.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the sale, the insider now directly owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. Insiders have sold 76,174 shares of company stock valued at $14,981,909 in the last three months. 0.89% of the stock is owned by corporate insiders.
Hedge funds have recently modified their holdings of the business. Honeywell International Inc. bought a new stake in UnitedHealth Group during the first quarter worth about $35,262,000. Schwab Charles Investment Management Inc. lifted its stake in UnitedHealth Group by 5.3% during the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after purchasing an additional 183,401 shares during the last quarter. Suntrust Banks Inc. lifted its stake in UnitedHealth Group by 8.5% during the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock worth $42,774,000 after purchasing an additional 20,541 shares during the last quarter. Factory Mutual Insurance Co. lifted its stake in UnitedHealth Group by 20.9% during the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock worth $77,245,000 after purchasing an additional 72,000 shares during the last quarter. Finally, Shell Asset Management Co. lifted its stake in UnitedHealth Group by 0.8% during the second quarter. Shell Asset Management Co. now owns 157,241 shares of the healthcare conglomerate’s stock worth $29,156,000 after purchasing an additional 1,254 shares during the last quarter. 86.11% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with our FREE daily email newsletter.